Drugs / Pfs48/45
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT05400746 | Nov 2022 → Oct 2023 | Plasmodium falciparum malaria | University of Oxford | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pfs48/45 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05400746 ↗ |
| Modality | Vaccine | “malaria vaccine candidate Pfs48/45 in Matrix-M adjuvant” NCT05400746 ↗ |